Wenger Vieli, a prominent law firm with a history of dynamic leadership changes every 1.5 years, has announced the appointment of Pascal Honold as the new Managing Partner, effective January 1, 2024. Honold has extensive expertise in the
Altenburger advised Kylian Mbappé in a long-term strategic partnership with Loewe. Soccer superstar will be the worldwide brand ambassador of the brand, a global player in the luxury segment of the consumer electronics industry. Mbappé
Niederer Kraft Frey advised Calibre Scientific on the acquisition of Bioreba, a Swiss biotech company and provider of plant pathogen diagnostic test kits and services, selling to diagnostic labs, universities, public and private research institutions
Proteomedix, a Swiss private, commercial-stage diagnostics oncology company and Water Biotech are forming together a company called Onconetix. The transaction is implemented by the acquisition of Proteomedix for an all stock consideration. Onconetix’s commercial
AXA Investment Managers Schweiz is planning to merge three real estate funds. The new “AXA Real Estate Fund Switzerland” is set to become the largest real estate fund – based on NAV – for pension fund investors
AC Immune, a Swiss clinical stage biopharmaceutical company pioneering in precision medicine for neurodegenerative diseases listed on the Nasdaq completed an underwritten offering of 14.3 million of its common shares at a price of USD 3.50 per
Leonteq, a Swiss fintech company, received advisory support from Niederer Kraft Frey in its acquisition of a 10% stake in the Swiss stock exchange BX Swis, which is an established stock exchange based in Zurich whose
Birgit Sambeth, partner at Altenburger and former President of the Swiss Bar Association, has been elected to the Board of Directors of Aéroport international de Genève (AIG), which plays a crucial role in
Schellenberg Wittmer advised Bioventure Club Deal Nine & Co KG in a Series C financing round of the Swiss Aphaia companies, which are clinical-stage pharmaceutical companies that have developed proprietary treatment methods targeting obesity and
Baker McKenzie advised Swissroc Industrial Opportunities and Groupe Orllati on their acquisition of approximately 60,000 square meters of freehold land in the heart of Geneva’s Zone Industrielle de Meyrin Satigny (ZIMEYSA) from the Stellantis Group
